All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
Medicina is published by MDPI from Volume 54 Issue 1 (2018).
Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence,
and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Background and objective. Alzheimer’s disease is a progressive neurodegenerative disease that is biochemically characterized by the accumulation of amyloid beta (Aβ) peptides in the brain. The current hypothesis suggests that Aβ oligomers rather than fibrillar aggregates are the most toxic species of Aβ though the mechanisms of their neurotoxicity are unclear. The authors have previously shown that small Aβ1–42 oligomers at around 1 μM concentration caused rapid (in 24 h) neuronal death in cerebellar granule cell (CGC) cultures. In this study, we aimed to investigate whether protracted (up to 7 days) incubation of CGC cultures with lower submicromolar concentration of various aggregates of Aβ1–42 had an effect on viability of neurons. In order to get some insight into the mechanism of Aβ-induced cell death, we also sought to determine whether extracellular Ca2+ and process of endocytosis contributed to Aβ oligomer-induced neurotoxicity and whether pharmacological interventions into these processes would prevent Aβ oligomer-induced cell death. Material and Methods. Primary cultures of CGC were treated with various aggregate forms of Aβ1–42. Cell viability was assessed by fluorescent microscopy using propidium iodide and Hoechst 33342 staining. Results. Exposure of neurons to 500 nM Aβ1–42 oligomers for 72–168 h caused extensive neuronal necrosis. Lower concentrations (100–250 nM) were not toxic to cells during 7 days of incubation. Aβ1–42 monomers and fibrils had no effect on neuronal viability even after 7 days of incubation. Treatment of neurons with EGTA, steroid hormone 17β-estradiol, and methyl-β-cyclodextrin significantly reduced Aβ1-42 oligomers-induced neuronal death. Conclusions. The results show that submicromolar concentrations of Aβ1-42 oligomers were highly toxic to neurons during protracted incubation inducing neuronal necrosis that can be prevented by chelating extracellular Ca2+ with EGTA, inhibiting endocytosis with methyl-β-cyclodextrin, or by estradiol, which may protect against mitochondrial permeability transition pore opening.
Čižas, P.; Jekabsonė, A.; Borutaitė, V.; Morkūnienė, R.
Prevention of Amyloid-Beta Oligomer-Induced Neuronal Death by EGTA, Estradiol, and Endocytosis Inhibitor. Medicina2011, 47, 15.
https://doi.org/10.3390/medicina47020015
AMA Style
Čižas P, Jekabsonė A, Borutaitė V, Morkūnienė R.
Prevention of Amyloid-Beta Oligomer-Induced Neuronal Death by EGTA, Estradiol, and Endocytosis Inhibitor. Medicina. 2011; 47(2):15.
https://doi.org/10.3390/medicina47020015
Chicago/Turabian Style
Čižas, Paulius, Aistė Jekabsonė, Vilmantė Borutaitė, and Ramunė Morkūnienė.
2011. "Prevention of Amyloid-Beta Oligomer-Induced Neuronal Death by EGTA, Estradiol, and Endocytosis Inhibitor" Medicina 47, no. 2: 15.
https://doi.org/10.3390/medicina47020015
Article Metrics
No
No
Article Access Statistics
For more information on the journal statistics, click here.
Multiple requests from the same IP address are counted as one view.
Čižas, P.; Jekabsonė, A.; Borutaitė, V.; Morkūnienė, R.
Prevention of Amyloid-Beta Oligomer-Induced Neuronal Death by EGTA, Estradiol, and Endocytosis Inhibitor. Medicina2011, 47, 15.
https://doi.org/10.3390/medicina47020015
AMA Style
Čižas P, Jekabsonė A, Borutaitė V, Morkūnienė R.
Prevention of Amyloid-Beta Oligomer-Induced Neuronal Death by EGTA, Estradiol, and Endocytosis Inhibitor. Medicina. 2011; 47(2):15.
https://doi.org/10.3390/medicina47020015
Chicago/Turabian Style
Čižas, Paulius, Aistė Jekabsonė, Vilmantė Borutaitė, and Ramunė Morkūnienė.
2011. "Prevention of Amyloid-Beta Oligomer-Induced Neuronal Death by EGTA, Estradiol, and Endocytosis Inhibitor" Medicina 47, no. 2: 15.
https://doi.org/10.3390/medicina47020015